Trupanion, Inc. (NASDAQ:TRUP) Receives Consensus Rating of “Hold” from Brokerages

Trupanion, Inc. (NASDAQ:TRUP) has received an average rating of “Hold” from the six analysts that are presently covering the firm, Marketbeat reports. One analyst has rated the stock with a sell recommendation, three have given a hold recommendation and two have assigned a buy recommendation to the company. The average twelve-month target price among analysts that have covered the stock in the last year is $42.25.

Several research firms have issued reports on TRUP. Stifel Nicolaus dropped their price objective on Trupanion from $35.00 to $31.00 and set a “hold” rating for the company in a research note on Tuesday, March 31st. Weiss Ratings lowered Trupanion from a “hold (c-)” rating to a “sell (d+)” rating in a research note on Wednesday, March 4th. Zacks Research lowered Trupanion from a “strong-buy” rating to a “hold” rating in a research note on Friday, February 13th. Cantor Fitzgerald lowered their target price on Trupanion from $42.00 to $34.00 and set a “neutral” rating for the company in a research note on Thursday, April 9th. Finally, Piper Sandler lowered their target price on Trupanion from $60.00 to $45.00 and set an “overweight” rating for the company in a research note on Friday, February 13th.

Trupanion Stock Performance

Trupanion stock opened at $21.86 on Wednesday. The company has a debt-to-equity ratio of 0.25, a current ratio of 1.73 and a quick ratio of 1.73. The stock has a fifty day moving average price of $25.16 and a two-hundred day moving average price of $30.66. Trupanion has a 52-week low of $21.16 and a 52-week high of $57.88. The firm has a market capitalization of $953.53 million, a P/E ratio of 37.05 and a beta of 1.49.

Trupanion (NASDAQ:TRUP) last released its quarterly earnings data on Thursday, April 30th. The financial services provider reported $0.11 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.07 by $0.04. Trupanion had a return on equity of 6.87% and a net margin of 1.74%.The firm had revenue of $384.05 million during the quarter, compared to analyst estimates of $379.77 million. During the same period in the prior year, the company posted ($0.03) earnings per share. The business’s revenue for the quarter was up 12.3% compared to the same quarter last year. As a group, analysts anticipate that Trupanion will post 0.53 EPS for the current fiscal year.

Insider Activity

In other news, CRO Emily Dreyer sold 7,792 shares of the firm’s stock in a transaction on Wednesday, March 4th. The stock was sold at an average price of $28.15, for a total value of $219,344.80. Following the completion of the sale, the executive directly owned 35,627 shares in the company, valued at approximately $1,002,900.05. This trade represents a 17.95% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. Also, COO John R. Gallagher sold 5,283 shares of the firm’s stock in a transaction on Friday, February 27th. The shares were sold at an average price of $26.52, for a total value of $140,105.16. Following the completion of the sale, the chief operating officer owned 32,387 shares of the company’s stock, valued at approximately $858,903.24. This trade represents a 14.02% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last ninety days, insiders sold 16,773 shares of company stock worth $457,309. 5.42% of the stock is owned by corporate insiders.

Institutional Trading of Trupanion

Hedge funds and other institutional investors have recently made changes to their positions in the business. Federated Hermes Inc. acquired a new stake in shares of Trupanion in the third quarter valued at $33,000. Pilgrim Partners Asia Pte Ltd acquired a new stake in Trupanion in the third quarter worth about $39,000. Parallel Advisors LLC increased its position in Trupanion by 1,831.9% in the first quarter. Parallel Advisors LLC now owns 1,816 shares of the financial services provider’s stock worth $47,000 after purchasing an additional 1,722 shares during the period. Kemnay Advisory Services Inc. acquired a new stake in Trupanion in the fourth quarter worth about $64,000. Finally, Kelleher Financial Advisors acquired a new stake in Trupanion in the third quarter worth about $74,000.

About Trupanion

Trupanion, Inc is a pet medical insurance company that provides comprehensive insurance coverage for cats and dogs. The company’s core offering is a single, customizable medical policy designed to cover veterinary diagnostic tests, surgeries, hospital stays and congenital or hereditary conditions. Trupanion seeks to streamline the claims process by offering direct payment options to participating veterinarians, reducing the need for upfront payments by pet owners.

Founded in 1999 by Darryl Rawlings and headquartered in Seattle, Washington, Trupanion began operations in the early 2000s and has grown its presence through both digital channels and partnerships with veterinary hospitals.